Skip to content

Macronutrient Relations and Weight Loss in Obese Subjects

Effects of Macronutrient Relations on Body Weight, Body Composition, and Cardiovascular Risk Markers in Overweight Patients Attending a Telemedically Guided Weight Loss Program

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00868387
Enrollment
200
Registered
2009-03-25
Start date
2005-11-30
Completion date
2007-12-31
Last updated
2017-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

weight reduction, low-carbohydrate, body fat, telemedicine, cardiovascular risk markers

Brief summary

The burden of overweight and obesity has dramatically increased during the last decades. High carbohydrate intake, particularly refined carbohydrates, probably increase the risk of obesity, type 2 diabetes, and metabolic syndrome. There is evidence that energy-restricted low-carbohydrate diets show greater weight loss and better improvement of cardiovascular risk markers compared to energy-restricted low-fat diets. Beside macronutrient relations, efficacy of weight loss programs depends on care and control. The investigators aim to investigate whether or not a carbohydrate-restricted telemedically guided weight loss program results in a more pronounced weight loss and influences metabolic risk markers more beneficial than a fat-restricted diet.

Detailed description

see brief summary.

Interventions

OTHERenergy-restricted, CHO-restricted diet

carbohydrate content of the diet \< 40% Frequency: daily Duration: 12 months

OTHERenergy-restricted, CHO-rich diet

carbohydrate content of diet \> 55% Frequency: daily Duration: 12 months

Sponsors

Heart and Diabetes Center North-Rhine Westfalia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* age 18-70 years * body mass index \> 27 kg/m2

Exclusion criteria

* history of cardiovascular symptomatology * cholelithiasis * urolithiasis * insulin dependent diabetes * pacemaker implantation * pregnancy * lactation * vegetarianism

Design outcomes

Primary

MeasureTime frame
body weight12 months

Secondary

MeasureTime frame
waist circumference12 months
blood pressure12 months
blood lipids12 months
parameters of glucose metabolism12 months
fat massbaseline, 12 months

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026